Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,524 signal articles · 29 in last 24h · 122,283 total before filter · latest 1h ago
29last 24h
1255last 7d
211● bullish (7d)
151● bearish (7d)
205publishers
AllMacro211Earnings430M&A97Regulatory24Product9Analyst11
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Morning Bid: Damp Squib
Reuters37d agoneutral
Morning Bid: Damp Squib

What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets Another day, another test for chip stocks.

Bloomberg37d agoneutral
Retail Traders’ Rise Upends the Established Stock Market Order

(Bloomberg) -- Retail traders have moved from the stock market’s margins to its center.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsOpenAI’s First Device Will Be Movable, Screenless Speaker Built as AI CompanionCIA Says AI Drones Give Russian Troops Only 30 Minutes to LiveBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthOnePlus, Once Popular with Tech Fans, to Pull Out of US and EuropeMarket data shows that their growing influence has reache

Bloomberg37d agoneutral
Middle East Bond Spreads Hit 2022 High as Ceasefire Breaks Down

(Bloomberg) -- Bond investors are demanding the most compensation since October 2022 to fund Middle Eastern governments as fighting flares again between the US and Iran.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsOpenAI’s First Device Will Be Movable, Screenless Speaker Built as AI CompanionCIA Says AI Drones Give Russian Troops Only 30 Minutes to LiveBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthOnePlus, Once Popular with Tech Fans, to

Health Care Roundup: Market Talk
The Wall Street Journal37d agoneutral
Health Care Roundup: Market Talk

Find insight on Johnson & Johnson, Rubber Industries, and more in the latest Market Talks covering health care.

🔎 Under the Radar: AtaiBeckley Stock Soars on Eli Lilly Deal
The Wall Street Journal37d agobullish
🔎 Under the Radar: AtaiBeckley Stock Soars on Eli Lilly Deal

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing a recent buying spree. Eli will pay $6.75 a share in cash for the biopharma company, a 26% premium to yesterday's closing price of $5.

UNH Stock Flashes Buy Signal On Massive Earnings Beat
Investor's Business Daily37d agobullish
UNH Stock Flashes Buy Signal On Massive Earnings Beat

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

US probes Samsung for alleged infringement of Netlist's memory-chip patents
Reuters37d agobearish
US probes Samsung for alleged infringement of Netlist's memory-chip patents

U.S. trade regulators have launched ‌a probe into ‌Samsung Electronics' memory chips and ​products sold by Google, Nvidia, Broadcom and Super Micro Computer that use ‌them ⁠after a complaint by Netlist alleging infringement ⁠of its patents. California-based Netlist has accused Samsung ​and its ​U.S. ​units of ‌infringing its patents on dynamic random access memory, a type of chip that temporarily stores data ‌for processors ​and is a ​critical ​component in the ‌servers powering the ​AI ​boom, the U.S. International Trade Commission (USITC) said ​on ‌Wednesday.

Investing.com37d agobullish
UnitedHealth shares surge on strong earnings beat and guidance

Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

Look Out Below When the Price Isn’t Right
The Wall Street Journal37d agoneutral
Look Out Below When the Price Isn’t Right

The red-hot Korean memory-chip maker raised $26.51 billion last week by selling American depositary receipts, which U.S. investors can buy in dollars. The violation of the “Law of One Price” happens when it’s hard for sophisticated traders to profit from such differences and often when many novice investors just piled into the market. The most famous example occurred a week before the tech bubble burst when Palm, the maker of then-popular Palm Pilots, was partially sold by parent 3Com.

AI Weekly: SK Hynix shares jump up and down, Apple sues OpenAI
Reuters Videos37d agobullishVIDEO
AI Weekly: SK Hynix shares jump up and down, Apple sues OpenAI

<body><p>STORY: From SK Hynix shares yo-yoing to Apple suing OpenAI...</p><p>This is AI Weekly.</p><p>:: AI Weekly</p><p>SK Hynix shares went on a wild ride after its U.S. listing last week.</p><p>Shares plunged 15% in trading on Monday, marking the South Korean chip giant's biggest one-day fall on record.</p><p>But the firm's stock bounced back almost 13% later in the week.</p><p>It followed gains made in U.S. tech stocks after softer-than-expected U.S. inflation data and upbeat analyst forecasts for AI memory demand.</p><p>Meta plans to produce AI chips this September.</p><p>That's according to a memo seen by Reuters.</p><p>The move would help Meta gain more independence from chip suppliers like Nvidia.</p><p>Apple sued OpenAI and two former employees.</p><p>The U.S. tech giant alleged misappropriation of its trade secrets to benefit the ChatGPT-maker's move into consumer hardware.</p><p>It accused OpenAI of orchestrating an effort to acquire and exploit Apple's confidential information through former employees, recruiting practices and supplier relations.</p><p>OpenAI said in a statement they "have no interest in other companies’ trade secrets."</p><p>IBM shares plunged by a quarter in one day.</p><p>Investors sold off after the U.S. tech company signaled the AI infrastructure boom has drawn spending away from the software sector.</p><p>IBM said it expected revenue to rise just 1% in the second quarter, falling short of Wall Street hopes.</p><p>The announcement added to worries over a software industry already rocked by the rise of AI tools.</p><p>And TSMC raised it forecast for capital spending by up to 14% for this year.</p><p>It comes after the chipmaker and major Nvidia supplier posted a 77% jump in second-quarter profit of $22 billion.</p><p>That was well ahead of market forecasts and the firm's ninth straight quarter of double-digit percentage growth.</p><p>Looking ahead, capital expenditure for this year is forecast to now be between $60 billion and $64 billion.</p></body>

South Korea Cracks Down on Leveraged ETFs Amid Big Swings in Chip Stocks
The Wall Street Journal37d agoneutral
South Korea Cracks Down on Leveraged ETFs Amid Big Swings in Chip Stocks

The Financial Services Commission said today that it would suspend new listings of single-stock leveraged exchange-traded funds and triple the minimum deposit requirement to 30 million won, or about $20,285. Leveraged ETFs tied to individual companies have surged in popularity around the world as investors have become eager to supersize their returns on chip stocks and other hot trades. A 2x leveraged ETF tracking SK Hynix, for example, would rise 10% on a day when the stock climbs 5%.

US markets steady as TSMC delivers record profit and investors await key economic data: Dow Jones, S&P, Nasdaq, Wall Street Futures
InvestorsHub37d agoneutral
US markets steady as TSMC delivers record profit and investors await key economic data: Dow Jones, S&P, Nasdaq, Wall Street Futures

US stock futures traded close to flat on Thursday as investors weighed encouraging inflation data, another strong round of corporate earnings and ongoing geopolitical tensions in the Middle East. Market attention also turned to a busy schedule of economic releases and earnings reports that could shape sentiment for the remainder of the week.